tiprankstipranks
AngioDynamics (DE:UG2)
FRANKFURT:UG2
Germany Market

AngioDynamics (UG2) Blogger Opinions & Sentiment

1 Followers

Blogger Sentiment

Bullish: 66.00%
Sector Average
Bullish
DE:UG2 Blogger sentiment is based on 6 Blogger Opinions. The Blogger sentiment is more Bullish than other stocks in the Healthcare sector.

Blogger Article Distribution

ArticleDistribution
33% Zacks
33% SeekingAlpha
16% GuruFocus
18% Others
The distribution of articles among the main online Financial Blogging platforms.

Top Blogger Bearish Predictions

Is AngioDynamics Inc (ANGO) Overvalued After Q4 Earnings Miss? EPS at -$0.07 on $86.6 Million Revenue; GF Score: 62/100
GuruFocus
Recent negative articles by top bloggers.

Top Blogger Bullish Predictions

Freedom Broker raises AngioDynamics stock price target to $17 on margin outlook
Investing
Reasons to Add AngioDynamics Stock to Your Portfolio for Now
Zacks
AngioDynamics: Discounted Sales Multiple With Real Growth Engines
SeekingAlpha
Recent positive articles by top bloggers.

Financial Blogger Predictions​​

Blogger Performance
Any
Any
Blogger Sentiment
Any
Any

FAQ

What do Seeking Alpha bloggers think of DE:UG2?
Seeking Alpha’s Grassroots Trading has a Bullish Sentiment.
    What do Motley Fool contributors think of DE:UG2?
    Currently there's no blogger sentiment for DE:UG2.
    What Is DE:UG2’s Blogger Sentiment?
    DE:UG2’s Blogger Sentiment is Bullish.
      What was the most recent blogger prediction for DE:UG2?
      The most recent blogger prediction for DE:UG2 was made by Harshit Gupta, who was Bearish on the stock.
        How can I follow the stock ratings of top Top Financial Bloggers?
        Head over to our Expert Center to see a list of the Top 100 Financial Bloggers and follow the financial bloggers of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Stocks with the Highest Top Blogger Ratings in the Healthcare sector
          CADLCandel Therapeutics
          MLTXMoonLake Immunotherapeutics
          DFTXDefinium Therapeutics
          TGTXTG Therapeutics
          PGENPrecigen